688 related articles for article (PubMed ID: 20448207)
21. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide-1(9-36) inhibits chemokine-induced migration of human CD4-positive lymphocytes.
Liberman A; Esser M; Marx N; Burgmaier M
PLoS One; 2013; 8(3):e58445. PubMed ID: 23469279
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
24. Exendin-4 protects bone marrow-derived mesenchymal stem cells against oxygen/glucose and serum deprivation-induced apoptosis through the activation of the cAMP/PKA signaling pathway and the attenuation of ER stress.
He J; Wang C; Sun Y; Lu B; Cui J; Dong N; Zhang M; Liu Y; Yu B
Int J Mol Med; 2016 Apr; 37(4):889-900. PubMed ID: 26935620
[TBL] [Abstract][Full Text] [Related]
25. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat.
Yang H; Li H; Wang Z; Shi Y; Jiang G; Zeng F
J Surg Res; 2013 Dec; 185(2):825-32. PubMed ID: 23890403
[TBL] [Abstract][Full Text] [Related]
26. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
27. The glucagon-like peptide 1 receptor agonist enhances intrinsic peroxisome proliferator-activated receptor γ activity in endothelial cells.
Onuma H; Inukai K; Kitahara A; Moriya R; Nishida S; Tanaka T; Katsuta H; Takahashi K; Sumitani Y; Hosaka T; Ishida H
Biochem Biophys Res Commun; 2014 Aug; 451(2):339-44. PubMed ID: 25109805
[TBL] [Abstract][Full Text] [Related]
28. Dipeptidyl peptidase-4 inhibition in diabetic rats leads to activation of the transcription factor CREB in β-cells.
Pugazhenthi S; Qin L; Bouchard R
Eur J Pharmacol; 2015 May; 755():42-9. PubMed ID: 25720341
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
[TBL] [Abstract][Full Text] [Related]
30. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
[TBL] [Abstract][Full Text] [Related]
31. Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element.
Kim MJ; Kang JH; Park YG; Ryu GR; Ko SH; Jeong IK; Koh KH; Rhie DJ; Yoon SH; Hahn SJ; Kim MS; Jo YH
J Endocrinol; 2006 Mar; 188(3):623-33. PubMed ID: 16522741
[TBL] [Abstract][Full Text] [Related]
32. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
Sudre B; Broqua P; White RB; Ashworth D; Evans DM; Haigh R; Junien JL; Aubert ML
Diabetes; 2002 May; 51(5):1461-9. PubMed ID: 11978643
[TBL] [Abstract][Full Text] [Related]
33. Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation.
Li AQ; Zhao L; Zhou TF; Zhang MQ; Qin XM
Am J Physiol Cell Physiol; 2015 Jan; 308(2):C164-75. PubMed ID: 25377089
[TBL] [Abstract][Full Text] [Related]
34. Dipeptidyl peptidase-4 inhibition attenuates arrhythmias via a protein kinase A-dependent pathway in infarcted hearts.
Lee TM; Chen WT; Chang NC
Circ J; 2015; 79(11):2461-70. PubMed ID: 26399925
[TBL] [Abstract][Full Text] [Related]
35. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
36. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
[TBL] [Abstract][Full Text] [Related]
37. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway.
Liu J; Yin F; Zheng X; Jing J; Hu Y
Neurochem Int; 2007; 51(6-7):361-9. PubMed ID: 17629357
[TBL] [Abstract][Full Text] [Related]
38. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
Akarte AS; Srinivasan BP; Gandhi S
J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
40. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
